GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 239 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2019. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $741,000 | -46.3% | 13,435 | -38.5% | 0.02% | -47.5% |
| Q2 2020 | $1,380,000 | +24.4% | 21,859 | +0.7% | 0.04% | -2.4% |
| Q1 2020 | $1,109,000 | -25.6% | 21,706 | +15.7% | 0.04% | +13.9% |
| Q4 2019 | $1,491,000 | +57.9% | 18,763 | -3.6% | 0.04% | +56.5% |
| Q3 2019 | $944,000 | -13.4% | 19,464 | -6.1% | 0.02% | -11.5% |
| Q2 2019 | $1,090,000 | – | 20,726 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 327,905 | $17,248,000 | 9.44% |
| Asymmetry Capital Management, L.P. | 314,217 | $16,528,000 | 8.95% |
| Perceptive Advisors | 5,775,726 | $303,803,000 | 6.97% |
| NEXTHERA CAPITAL LP | 142,305 | $7,485,000 | 6.23% |
| Grace Capital | 244,914 | $12,882,000 | 6.14% |
| Broadfin Capital, LLC | 316,619 | $16,654,000 | 3.62% |
| Ghost Tree Capital, LLC | 300,000 | $15,780,000 | 3.27% |
| ArchPoint Investors | 156,635 | $8,239,000 | 2.61% |
| STANSBERRY ASSET MANAGEMENT, LLC | 114,562 | $6,026,000 | 2.37% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 13,928 | $733,000 | 2.07% |